![Jonathan R. McGrath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan R. McGrath
Directeur Général chez Neograft Technologies, Inc.
Postes actifs de Jonathan R. McGrath
Sociétés | Poste | Début | Fin |
---|---|---|---|
Neograft Technologies, Inc.
![]() Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | Directeur Général | - | - |
President | - | - | |
Treasurer | - | - |
Historique de carrière de Jonathan R. McGrath
Anciens postes connus de Jonathan R. McGrath
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioSphere Medical, Inc.
![]() BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Directeur Technique/Scientifique/R&D | 01/01/1999 | 01/01/2005 |
UROLOGIX, INC. | Directeur Technique/Scientifique/R&D | 01/01/1995 | 01/01/1998 |
PFIZER, INC. | Directeur Technique/Scientifique/R&D | 01/01/1990 | 01/01/1995 |
LumeRx, Inc.
![]() LumeRx, Inc. Medical SpecialtiesHealth Technology LumeRx, Inc. develops radiation technology that eliminates bacteria. It provides minimally invasive and light-based devices for the treatment of peptic ulcer disease. The company was founded by Robert A. Ganz and is headquartered in Newton, MA. | President | - | - |
Formation de Jonathan R. McGrath
University of Vermont | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
President | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
UROLOGIX, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
LumeRx, Inc.
![]() LumeRx, Inc. Medical SpecialtiesHealth Technology LumeRx, Inc. develops radiation technology that eliminates bacteria. It provides minimally invasive and light-based devices for the treatment of peptic ulcer disease. The company was founded by Robert A. Ganz and is headquartered in Newton, MA. | Health Technology |
BioSphere Medical, Inc.
![]() BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
Neograft Technologies, Inc.
![]() Neograft Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Neograft Technologies, Inc. engages in the research and development in tissue engineering and regenerative medicine. Its product Angioshield, addresses inherent limits associated with using veins for coronary bypass surgery. The company was founded by Mohammed El-Kurdi in 2009 and is headquartered in Taunton, MA. | Commercial Services |
- Bourse
- Insiders
- Jonathan R. McGrath
- Expérience